{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-067062","form_type":"8-K","ticker":"ATEC","cik":"0001350653","company_name":"Alphatec Holdings, Inc.","filed_at":"2026-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.903361+00:00","generated_at":"2026-05-16T00:44:49.576412+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Alphatec FY2025 revenue $764M (+25% YoY); guides FY2026 ~$890M, raises EBITDA guidance","bullets":["Full-year 2025 total revenue $764M (+25% YoY); GAAP net loss $143M; non-GAAP net income $8M.","Q4 2025 revenue $213M; adjusted EBITDA $33M (16% margin), expanding 390 bps YoY; positive Q4 free cash flow $8M.","FY2026 guidance: revenue ~$890M (+17%); adj. EBITDA ~$134M (15% of rev, up from $130M); FCF >=$20M.","Surgical revenue $190M in Q4 (+21% YoY); net new surgeon users +23% in Q4, +20% full year.","Valence intraoperative platform cleared and released; EOS Insight proliferation noted."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-067062","json":"https://secwatch.observer/filing/0001193125-26-067062.json","markdown":"https://secwatch.observer/filing/0001193125-26-067062.md","text":"https://secwatch.observer/filing/0001193125-26-067062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1350653/000119312526067062/0001193125-26-067062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1350653/000119312526067062/atec-20260224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:44:49.576412+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}